SANTAMARIA; Pedro

Patent Applications and Registrations

Patent applications and USPTO patent grants for SANTAMARIA; Pedro.The latest application filed is for "nanoparticles comprising non-classical mhc and uses thereof".

Company Profile

7.16.29

SANTAMARIA; Pedro - Calgary CA
Santamaria; Pedro - Calbary CA
Santamaria; Pedro - Minneapolis MN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nanoparticles Comprising Non-classical Mhc And Uses Thereof App 20220211868 - SANTAMARIA; Pedro	2022-07-07
Methods and compositions for sustained immunotherapy Grant 11,338,024 - Santamaria May 24, 2	2022-05-24
Methods Of Treating Liver Disease App 20220089682 - SANTAMARIA; Pedro	2022-03-24
Methods And Compositions For Treating Inflammation App 20210230237 - SANTAMARIA; Pedro	2021-07-29
Methods And Compositions For Treating Multiple Sclerosis And Related Disorders App 20210205470 - SANTAMARIA; Pedro	2021-07-08
Compositions And Methods For The Prevention And Treatment Of Autoimmune Conditions App 20210145949 - SANTAMARIA; Pedro ; et al.	2021-05-20
Compositions and methods for the prevention and treatment of cancer Grant 11,000,596 - Santamaria May 11, 2	2021-05-11
Methods and compositions for treating inflammation Grant 10,988,516 - Santamaria April 27, 2	2021-04-27
Methods and compositions for treating multiple sclerosis and related disorders Grant 10,905,773 - Santamaria February 2, 2	2021-02-02
Methods Of Treating Autoimmune Disease App 20200390856 - SANTAMARIA; Pedro	2020-12-17
Assay To Measure The Potency Of Receptor-ligand Interactions In Nanomedicines App 20200057048 - SANTAMARIA; Pedro	2020-02-20
Methods and compositions for treating multiple sclerosis and related disorders App 20200009265 - Santamaria; Pedro	2020-01-09
Nanoparticle compositions for sustained therapy Grant 10,485,882 - Santamaria Nov	2019-11-26
Methods For Treating Autoimmune Disease Using Biocompatible Bioabsorbable Nanospheres App 20190134171 - SANTAMARIA; Pedro	2019-05-09
Compositions And Methods For The Prevention And Treatment Of Cancer App 20190076545 - Santamaria; Pedro	2019-03-14
Nanoparticle Compositions For Sustained Therapy App 20190060484 - SANTAMARIA; Pedro	2019-02-28
Methods And Compositions For Sustained Immunotherapy App 20190060427 - Santamaria; Pedro	2019-02-28
Compositions and methods for the prevention and treatment of cancer Grant 10,172,955 - Santamaria J	2019-01-08
Methods and compositions for sustained immunotherapy Grant 10,124,045 - Santamaria November 13, 2	2018-11-13
Methods and compositions for treating multiple sclerosis and related disorders Grant 10,080,808 - Santamaria September 25, 2	2018-09-25
RECOMBINANT pMHC CLASS II MOLECULES App 20180127481 - SANTAMARIA; Pedro	2018-05-10
Compositions And Methods For The Prevention And Treatment Of Autoimmune Conditions App 20170333540 - Santamaria; Pedro ; et al.	2017-11-23
Methods And Compositions For Treating Multiple Sclerosis And Related Disorders App 20170312348 - Santamaria; Pedro	2017-11-02
Compositions And Methods For The Prevention And Treatment Of Cancer App 20170274096 - Santamaria; Pedro	2017-09-28
Nanoparticle Compositions For Sustained Therapy App 20170095544 - Santamaria; Pedro	2017-04-06
Methods and compositions for treating multiple sclerosis and related disorders Grant 9,603,948 - Santamaria March 28, 2	2017-03-28
Compositions and methods for the prevention and treatment of cancer Grant 9,511,151 - Santamaria December 6, 2	2016-12-06
Compositions And Methods For The Prevention And Treatment Of Autoimmune Conditions App 20160271237 - Santamaria; Pedro	2016-09-22
Methods And Compositions For Treating Multiple Sclerosis And Related Disorders App 20150250871 - Santamaria; Pedro	2015-09-10
Methods And Compositions For Treating Multiple Sclerosis And Related Disorders App 20150209446 - Santamaria; Pedro	2015-07-30
Methods And Compositions For Sustained Immunotherapy App 20150125536 - Santamaria; Pedro	2015-05-07
Methods And Compositions For Treating Multiple Sclerosis And Related Disorders App 20140105980 - Santamaria; Pedro	2014-04-17
Methods And Compositions For Treating Inflammation App 20130330414 - Santamaria; Pedro	2013-12-12
Compositions And Methods For The Prevention And Treatment Of Autoimmune Conditions App 20130302421 - Santamaria; Pedro ; et al.	2013-11-14
Compositions and methods for the prevention and treatment of autoimmune conditions Grant 8,354,110 - Santamaria , et al. January 15, 2	2013-01-15
Compositions And Methods For The Prevention And Treatment Of Cancer App 20120121649 - Santamaria; Pedro	2012-05-17
Methods For Treating Autoimmune Disease Using Biocompatible Bioabsorbable Nanospheres App 20120093934 - Santamaria; Pedro	2012-04-19
Compositions And Methods For The Prevention And Treatment Of Autoimmune Conditions App 20110059121 - Santamaria; Pedro ; et al.	2011-03-10
Compositions And Methods For The Prevention And Treatment Of Autoimmune Conditions App 20090155292 - SANTAMARIA; Pedro ; et al.	2009-06-18
DNA sequence-based HLA typing method Grant 5,629,149 - Santamaria , et al. * May 13, 1	1997-05-13
DNA sequence-based HLA class I typing method Grant 5,593,830 - Santamaria , et al. * January 14, 1	1997-01-14
DNA sequence-based HLA class I typing method Grant 5,424,184 - Santamaria , et al. June 13, 1	1995-06-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.